Ylva Tranæus Lindblad1,2,3, Georgios Vavilis4,5, Milan Chromek6,7, Abdul Rashid Quershi8, Christian Löwbeer9,10, Peter Bárány7,8. 1. Divisions of Pediatrics, CLINTEC, Karolinska Institutet, Stockholm, Sweden. ylva.tranaeus@ki.se. 2. Department of Pediatrics, Karolinska University Hospital, Stockholm, Sweden. ylva.tranaeus@ki.se. 3. Huddinge BUMM, Paradistorget 4, 5tr, S-141 47, Huddinge, Sweden. ylva.tranaeus@ki.se. 4. Department of Medicine, Karolinska Institutet, Stockholm, Sweden. 5. Division of Coronary and Valvular Heart Disease, Karolinska University Hospital, Stockholm, Sweden. 6. Divisions of Pediatrics, CLINTEC, Karolinska Institutet, Stockholm, Sweden. 7. Department of Pediatrics, Karolinska University Hospital, Stockholm, Sweden. 8. Renal Medicine, CLINTEC, Karolinska Institutet, Stockholm, Sweden. 9. Division of Clinical Chemistry, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden. 10. Department of Clinical Chemistry at SYNLAB Medilab, Täby, Sweden.
Abstract
BACKGROUND: The N-terminal pro-B-type natriuretic peptide (NT-proBNP) and high-sensitive cardiac-specific troponin T (hs-cTnT) are associated with abnormal cardiac structure and function and an increased risk of cardiovascular death in chronic kidney disease (CKD) patients. There is limited knowledge about these cardiac markers in pediatric CKD patients. METHODS: Longitudinal levels of NT-proBNP and hs-cTnT were analyzed in 48 pediatric patients, 22 with CKD (GFR range 8.8-68 mL/min/1.73 m2) and 26 transplanted patients (CKD-T; GFR range 30-99 mL/min/1.73 m2). Follow-up was scheduled after 1 and 3 years. Longitudinal patterns and associations to kidney function, cardiovascular risk markers, and echocardiographic parameters were assessed. RESULTS: High NT-proBNP was present in 27% of CKD and 11% of CKD-T patients. Similarly 32% of CKD and 8% of CKD-T patients had elevated hs-cTnT levels. In longitudinal multivariate analyses, high log NT-proBNP was associated with low GFR (β = - 0.01, p = 0.01) and elevated left ventricular mass index (LVMI; β = 0.02, p = 0.05). The strong association to LVMI remained when using GFR-adjusted NT-proBNP in similar analysis. Patients with left ventricular hypertrophy (LVH) also had higher NT-proBNP (235 [146-301] ng/L) than patients without LVH (86 [11-477] ng/L), p = 0.02. High hs-cTnT over-time was also associated with low GFR (β = - 0.007, p = 0.01) and a low cc-TDI e´/a´, indicating a worse LV diastolic function (β = - 0.09, p = 0.05). This association did not persist for GFR-adjusted hs-cTnT. CONCLUSIONS: NT-proBNP and hs-cTnT are elevated in pediatric CKD and CKD-T patients. GFR-adjusted NT-proBNP was associated with longitudinal levels of elevated LVMI suggesting this might be a marker for early subclinical myocardial damage. A higher resolution version of the Graphical abstract is available as Supplementary information.
BACKGROUND: The N-terminal pro-B-type natriuretic peptide (NT-proBNP) and high-sensitive cardiac-specific troponin T (hs-cTnT) are associated with abnormal cardiac structure and function and an increased risk of cardiovascular death in chronic kidney disease (CKD) patients. There is limited knowledge about these cardiac markers in pediatric CKD patients. METHODS: Longitudinal levels of NT-proBNP and hs-cTnT were analyzed in 48 pediatric patients, 22 with CKD (GFR range 8.8-68 mL/min/1.73 m2) and 26 transplanted patients (CKD-T; GFR range 30-99 mL/min/1.73 m2). Follow-up was scheduled after 1 and 3 years. Longitudinal patterns and associations to kidney function, cardiovascular risk markers, and echocardiographic parameters were assessed. RESULTS: High NT-proBNP was present in 27% of CKD and 11% of CKD-T patients. Similarly 32% of CKD and 8% of CKD-T patients had elevated hs-cTnT levels. In longitudinal multivariate analyses, high log NT-proBNP was associated with low GFR (β = - 0.01, p = 0.01) and elevated left ventricular mass index (LVMI; β = 0.02, p = 0.05). The strong association to LVMI remained when using GFR-adjusted NT-proBNP in similar analysis. Patients with left ventricular hypertrophy (LVH) also had higher NT-proBNP (235 [146-301] ng/L) than patients without LVH (86 [11-477] ng/L), p = 0.02. High hs-cTnT over-time was also associated with low GFR (β = - 0.007, p = 0.01) and a low cc-TDI e´/a´, indicating a worse LV diastolic function (β = - 0.09, p = 0.05). This association did not persist for GFR-adjusted hs-cTnT. CONCLUSIONS: NT-proBNP and hs-cTnT are elevated in pediatric CKD and CKD-T patients. GFR-adjusted NT-proBNP was associated with longitudinal levels of elevated LVMI suggesting this might be a marker for early subclinical myocardial damage. A higher resolution version of the Graphical abstract is available as Supplementary information.
Authors: Sherif F Nagueh; Christopher P Appleton; Thierry C Gillebert; Paolo N Marino; Jae K Oh; Otto A Smiseth; Alan D Waggoner; Frank A Flachskampf; Patricia A Pellikka; Arturo Evangelisa Journal: Eur J Echocardiogr Date: 2009-03
Authors: Frederic Dallaire; Cameron Slorach; Wei Hui; Taisto Sarkola; Mark K Friedberg; Timothy J Bradley; Edgar Jaeggi; Andreea Dragulescu; Ronnie L H Har; David Z I Cherney; Luc Mertens Journal: Circ Cardiovasc Imaging Date: 2015-02 Impact factor: 7.792
Authors: Alberto Aimo; James L Januzzi; Giuseppe Vergaro; Andrea Ripoli; Roberto Latini; Serge Masson; Michela Magnoli; Inder S Anand; Jay N Cohn; Luigi Tavazzi; Gianni Tognoni; Jørgen Gravning; Thor Ueland; Ståle H Nymo; Hans-Peter Brunner-La Rocca; Antoni Bayes-Genis; Josep Lupón; Rudolf A de Boer; Akiomi Yoshihisa; Yasuchika Takeishi; Michael Egstrup; Ida Gustafsson; Hanna K Gaggin; Kai M Eggers; Kurt Huber; Ioannis Tentzeris; W H Wilson Tang; Justin L Grodin; Claudio Passino; Michele Emdin Journal: Int J Cardiol Date: 2018-10-26 Impact factor: 4.164
Authors: F F Immer; F Stocker; A M Seiler; J P Pfammatter; D Bachmann; G Printzen; T Carrel Journal: J Am Coll Cardiol Date: 1999-05 Impact factor: 24.094
Authors: Justin T Saunders; Vijay Nambi; James A de Lemos; Lloyd E Chambless; Salim S Virani; Eric Boerwinkle; Ron C Hoogeveen; Xiaoxi Liu; Brad C Astor; Thomas H Mosley; Aaron R Folsom; Gerardo Heiss; Josef Coresh; Christie M Ballantyne Journal: Circulation Date: 2011-03-21 Impact factor: 29.690
Authors: Mark Mitsnefes; Joseph Flynn; Silvia Cohn; Joshua Samuels; Tom Blydt-Hansen; Jeffrey Saland; Thomas Kimball; Susan Furth; Bradley Warady Journal: J Am Soc Nephrol Date: 2009-11-16 Impact factor: 10.121
Authors: Nicholas C Chesnaye; Karolina Szummer; Peter Bárány; Olof Heimbürger; Hasan Magin; Tora Almquist; Fredrik Uhlin; Friedo W Dekker; Christoph Wanner; Kitty J Jager; Marie Evans Journal: J Am Heart Assoc Date: 2019-10-30 Impact factor: 5.501